Psyence Biomedical PBM
NASDAQ PBM
$4.12 -0.40 (-8.85%)
As of: Oct 22, 2026 · 3:59 PM EDT

Psyence Biomedical (PBM) Long-Term Investments (2022 - 2026)

Updated

Psyence Biomedical (PBM) recorded Long-Term Investments of $8.06 million in the quarter ended Mar 31, 2026.

Analysis

Psyence Biomedical (PBM) Long-Term Investments (2022 - 2026) Analysis & Trends

  • The figure for the quarter ended Mar 31, 2026 is the highest quarterly Long-Term Investments since the quarter ended Sep 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 266.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 297.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.56 Bn
10 Psyence Biomedical 2.33 Mn -20.33 Mn - 8.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 8.06 Mn
Sep 30, 2023 12.52 Mn
Dec 31, 2022 257.73 Mn
API Access

Psyence Biomedical Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=PBM&period=max&api_key=YOUR_API_KEY